Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 20;8(7):227.
doi: 10.3390/toxins8070227.

Toxin-Antitoxin Systems in Clinical Pathogens

Affiliations
Review

Toxin-Antitoxin Systems in Clinical Pathogens

Laura Fernández-García et al. Toxins (Basel). .

Abstract

Toxin-antitoxin (TA) systems are prevalent in bacteria and archaea. Although not essential for normal cell growth, TA systems are implicated in multiple cellular functions associated with survival under stress conditions. Clinical strains of bacteria are currently causing major human health problems as a result of their multidrug resistance, persistence and strong pathogenicity. Here, we present a review of the TA systems described to date and their biological role in human pathogens belonging to the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) and others of clinical relevance (Escherichia coli, Burkholderia spp., Streptococcus spp. and Mycobacterium tuberculosis). Better understanding of the mechanisms of action of TA systems will enable the development of new lines of treatment for infections caused by the above-mentioned pathogens.

Keywords: Toxin-Antitoxin; chromosome; clinical; pathogens; persistance; plasmids; resistance; virulence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Models representing the interaction between toxins and antitoxins in the different types of toxin-antitoxin (TA) systems. (A) Type I: the antitoxin mRNA binding to toxin mRNA, which prevents toxin protein formation; (B) type II: a TA complex is formed by the union of toxin and antitoxin proteins; (C) type III: a TA complex is formed by the union of toxin protein with antitoxin mRNA; (D) type IV: the antitoxin protein binds to the toxin target, blocking its action; (E) type V: the antitoxin mRNA encodes an RNAse that degrades the toxin mRNA.
Figure 2
Figure 2
Model of MazEFSa regulation. Transcription of the operon mazES-rsbUVW-sigB is initiated by the mazEF promoter, and transcription of the rsbUVW-sigB genes depends on the activity of the transcriptional terminator downstream of the mazE and mazF genes. This system is negatively regulated by the σB, encoded by sigB, which represses the mazEF promoter. Toxin MazF is an RNAse that degrades the mRNA in the UACAU site. The antitoxin MazE binds and inactivates the toxin MazF. This system is negatively regulated by the σB encoded by sigB.

References

    1. Makarova K.S., Wolf Y.I., Koonin E.V. Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol. Direct. 2009;4 doi: 10.1186/1745-6150-4-19. - DOI - PMC - PubMed
    1. Yamaguchi Y., Park J.H., Inouye M. Toxin-antitoxin systems in bacteria and archaea. Annu. Rev. Genet. 2011;45:61–79. doi: 10.1146/annurev-genet-110410-132412. - DOI - PubMed
    1. Mutschler H., Gebhardt M., Shoeman R.L., Meinhart A. A novel mechanism of programmed cell death in bacteria by toxin-antitoxin systems corrupts peptidoglycan synthesis. PLoS Biol. 2011;9 doi: 10.1371/journal.pbio.1001033. - DOI - PMC - PubMed
    1. Unoson C., Wagner E.G. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 2008;70:258–270. doi: 10.1111/j.1365-2958.2008.06416.x. - DOI - PubMed
    1. Leplae R., Geeraerts D., Hallez R., Guglielmini J., Drèze P., Van Melderen L. Diversity of bacterial type II toxin-antitoxin systems: a comprehensive search and functional analysis of novel families. Nucleic Acids Res. 2011;39:5513–5525. doi: 10.1093/nar/gkr131. - DOI - PMC - PubMed

Publication types

LinkOut - more resources